Cannabidiol consumers tend to rely on family members for data and sources of the popular substance. Here’s what that means for cannabis investors. Read More
Analyst Articles
Analysts who fret that the economy might overheat seem to have short memories. A year ago, the big worry was the “d” word…i.e., economic depression. Read More
Some analysts are fretting about high stock valuations, but the fact is, fast-rising earnings are catching up with equity price appreciation. Read More
A new report debunks the prohibitionist narrative that pot legalization encourages use among youth. Indeed, the data show that most kids are disinterested. Read More
In this Q&A, our in-house Sinologist discussses global trends that matter to investors, from East to West, and pinpoints specific investment opportunities. Read More
During the worst of the pandemic in 2020, a slew of firms slashed payouts. But this year as the economic recovery gains traction, dividends are rebounding. Read More
As celebrity canna-preneurs such as Snoop Dogg invest in marijuana IPOs, the industry is reaching new heights. Much of the focus is on CBD. Read More
Looking for reasonably priced growth plays outside of the usual universe of U.S.-based stocks? Cast an eye “across the pond” to Europe. Read More
As the bull market continues its winning ways, investors are starting to worry that valuations are excessive. Here why bullishness is warranted. Read More
Hopes were high when the Great White North legalized weed in 2018. Bullish expectations haven’t panned out. Here are the lessons for investors. Read More